A citation-based method for searching scientific literature

Mark J Graham, Richard G Lee, Teresa A Brandt, Li-Jung Tai, Wuxia Fu, Raechel Peralta, Rosie Yu, Eunju Hurh, Erika Paz, Bradley W McEvoy, Brenda F Baker, Nguyen C Pham, Andres Digenio, Steven G Hughes, Richard S Geary, Joseph L Witztum, Rosanne M Crooke, Sotirios Tsimikas. N Engl J Med 2017
Times Cited: 362







List of co-cited articles
1155 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
Frederick E Dewey, Viktoria Gusarova, Richard L Dunbar, Colm O'Dushlaine, Claudia Schurmann, Omri Gottesman, Shane McCarthy, Cristopher V Van Hout, Shannon Bruse, Hayes M Dansky,[...]. N Engl J Med 2017
441
53

Evinacumab for Homozygous Familial Hypercholesterolemia.
Frederick J Raal, Robert S Rosenson, Laurens F Reeskamp, G Kees Hovingh, John J P Kastelein, Paolo Rubba, Shazia Ali, Poulabi Banerjee, Kuo-Chen Chan, Daniel A Gipe,[...]. N Engl J Med 2020
211
39

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Joseph L Witztum, Daniel Gaudet, Steven D Freedman, Veronica J Alexander, Andres Digenio, Karren R Williams, Qingqing Yang, Steven G Hughes, Richard S Geary, Marcello Arca,[...]. N Engl J Med 2019
211
37

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
34

ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.
Nathan O Stitziel, Amit V Khera, Xiao Wang, Andrew J Bierhals, A Christina Vourakis, Alexandra E Sperry, Pradeep Natarajan, Derek Klarin, Connor A Emdin, Seyedeh M Zekavat,[...]. J Am Coll Cardiol 2017
244
32

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.
Kiran Musunuru, James P Pirruccello, Ron Do, Gina M Peloso, Candace Guiducci, Carrie Sougnez, Kiran V Garimella, Sheila Fisher, Justin Abreu, Andrew J Barry,[...]. N Engl J Med 2010
463
31

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia.
Daniel Gaudet, Ewa Karwatowska-Prokopczuk, Seth J Baum, Eunju Hurh, Joyce Kingsbury, Victoria J Bartlett, Amparo L Figueroa, Philip Piscitelli, Walter Singleton, Joseph L Witztum,[...]. Eur Heart J 2020
103
31

N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels.
Veronica J Alexander, Shuting Xia, Eunju Hurh, Steven G Hughes, Louis O'Dea, Richard S Geary, Joseph L Witztum, Sotirios Tsimikas. Eur Heart J 2019
109
29

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
28

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
Kausik K Ray, R Scott Wright, David Kallend, Wolfgang Koenig, Lawrence A Leiter, Frederick J Raal, Jenna A Bisch, Tara Richardson, Mark Jaros, Peter L J Wijngaard,[...]. N Engl J Med 2020
335
27

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
Sotirios Tsimikas, Ewa Karwatowska-Prokopczuk, Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth J Baum, Elizabeth Steinhagen-Thiessen, Michael D Shapiro, Erik S Stroes, Patrick M Moriarty, Børge G Nordestgaard,[...]. N Engl J Med 2020
320
27

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
26

ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.
Daniel Gaudet, Daniel A Gipe, Robert Pordy, Zahid Ahmad, Marina Cuchel, Prediman K Shah, Kuang-Yuh Chyu, William J Sasiela, Kuo-Chen Chan, Diane Brisson,[...]. N Engl J Med 2017
193
26

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
26

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
Jacy Crosby, Gina M Peloso, Paul L Auer, David R Crosslin, Nathan O Stitziel, Leslie A Lange, Yingchang Lu, Zheng-zheng Tang, He Zhang, George Hindy,[...]. N Engl J Med 2014
719
25

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Nicholas J Viney, Julian C van Capelleveen, Richard S Geary, Shuting Xia, Joseph A Tami, Rosie Z Yu, Santica M Marcovina, Steven G Hughes, Mark J Graham, Rosanne M Crooke,[...]. Lancet 2016
439
21

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.
Anders Berg Jørgensen, Ruth Frikke-Schmidt, Børge G Nordestgaard, Anne Tybjærg-Hansen. N Engl J Med 2014
606
21

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
19

Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance.
Rene C Adam, Ivory J Mintah, Corey A Alexa-Braun, Lisa M Shihanian, Joseph S Lee, Poulabi Banerjee, Sara C Hamon, Hye In Kim, Jonathan C Cohen, Helen H Hobbs,[...]. J Lipid Res 2020
69
27

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
Frederick J Raal, Raul D Santos, Dirk J Blom, A David Marais, Min-Ji Charng, William C Cromwell, Robin H Lachmann, Daniel Gaudet, Ju L Tan, Scott Chasan-Taber,[...]. Lancet 2010
643
18

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.
Frederick J Raal, David Kallend, Kausik K Ray, Traci Turner, Wolfgang Koenig, R Scott Wright, Peter L J Wijngaard, Danielle Curcio, Mark J Jaros, Lawrence A Leiter,[...]. N Engl J Med 2020
228
18

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.
Kevin Fitzgerald, Suellen White, Anna Borodovsky, Brian R Bettencourt, Andrew Strahs, Valerie Clausen, Peter Wijngaard, Jay D Horton, Jorg Taubel, Ashley Brooks,[...]. N Engl J Med 2017
391
18

Evinacumab in Patients with Refractory Hypercholesterolemia.
Robert S Rosenson, Lesley J Burgess, Christoph F Ebenbichler, Seth J Baum, Erik S G Stroes, Shazia Ali, Nagwa Khilla, Robert Hamlin, Robert Pordy, Yuping Dong,[...]. N Engl J Med 2020
88
20

Angiopoietin-like 3 in lipoprotein metabolism.
Sander Kersten. Nat Rev Endocrinol 2017
100
17

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
Frederick E Dewey, Viktoria Gusarova, Colm O'Dushlaine, Omri Gottesman, Jesus Trejos, Charleen Hunt, Cristopher V Van Hout, Lukas Habegger, David Buckler, Ka-Man V Lai,[...]. N Engl J Med 2016
297
17

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
Zahid Ahmad, Poulabi Banerjee, Sara Hamon, Kuo-Chen Chan, Aurelie Bouzelmat, William J Sasiela, Robert Pordy, Scott Mellis, Hayes Dansky, Daniel A Gipe,[...]. Circulation 2019
103
17

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
Daniel Gaudet, Veronica J Alexander, Brenda F Baker, Diane Brisson, Karine Tremblay, Walter Singleton, Richard S Geary, Steven G Hughes, Nicholas J Viney, Mark J Graham,[...]. N Engl J Med 2015
355
16

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Kausik K Ray, Harold E Bays, Alberico L Catapano, Narendra D Lalwani, LeAnne T Bloedon, Lulu R Sterling, Paula L Robinson, Christie M Ballantyne. N Engl J Med 2019
282
15

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
15

ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.
Viktoria Gusarova, Corey A Alexa, Yan Wang, Ashique Rafique, Jee Hae Kim, David Buckler, Ivory J Mintah, Lisa M Shihanian, Jonathan C Cohen, Helen H Hobbs,[...]. J Lipid Res 2015
132
15

Clinical review on triglycerides.
Ulrich Laufs, Klaus G Parhofer, Henry N Ginsberg, Robert A Hegele. Eur Heart J 2020
154
15

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M Ballantyne, Philip J Barter, Michael H Davidson, John J P Kastelein, Wolfgang Koenig, Darren K McGuire,[...]. JAMA 2020
261
15

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Ioanna Gouni-Berthold, Veronica J Alexander, Qingqing Yang, Eunju Hurh, Elisabeth Steinhagen-Thiessen, Patrick M Moriarty, Stephen G Hughes, Daniel Gaudet, Robert A Hegele, Louis St L O'Dea,[...]. Lancet Diabetes Endocrinol 2021
51
29

Common variants associated with plasma triglycerides and risk for coronary artery disease.
Ron Do, Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Chi Gao, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen,[...]. Nat Genet 2013
579
14

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
Kausik K Ray, Ulf Landmesser, Lawrence A Leiter, David Kallend, Robert Dufour, Mahir Karakas, Tim Hall, Roland P T Troquay, Traci Turner, Frank L J Visseren,[...]. N Engl J Med 2017
485
13

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
13

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
13

Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.
Mark J Graham, Richard G Lee, Thomas A Bell, Wuxia Fu, Adam E Mullick, Veronica J Alexander, Walter Singleton, Nick Viney, Richard Geary, John Su,[...]. Circ Res 2013
259
13

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
Toni I Pollin, Coleen M Damcott, Haiqing Shen, Sandra H Ott, John Shelton, Richard B Horenstein, Wendy Post, John C McLenithan, Lawrence F Bielak, Patricia A Peyser,[...]. Science 2008
477
13

Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3.
Alexandra C Chadwick, Niklaus H Evitt, Wenjian Lv, Kiran Musunuru. Circulation 2018
79
16

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Tetsuya Shimizugawa, Mitsuru Ono, Mitsuru Shimamura, Kenichi Yoshida, Yosuke Ando, Ryuta Koishi, Kenjiro Ueda, Toshimori Inaba, Hiroyuki Minekura, Takafumi Kohama,[...]. J Biol Chem 2002
259
13


Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
Anne C Goldberg, Lawrence A Leiter, Erik S G Stroes, Seth J Baum, Jeffrey C Hanselman, LeAnne T Bloedon, Narendra D Lalwani, Pragna M Patel, Xin Zhao, P Barton Duell. JAMA 2019
175
12

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
Yan Wang, Viktoria Gusarova, Serena Banfi, Jesper Gromada, Jonathan C Cohen, Helen H Hobbs. J Lipid Res 2015
119
12

Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Massimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, Cesare R Sirtori, Maria Giovanna Lupo, Nicola Ferri. Pharmacol Res 2020
31
38

Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Brian A Ference, John J P Kastelein, Kausik K Ray, Henry N Ginsberg, M John Chapman, Chris J Packard, Ulrich Laufs, Clare Oliver-Williams, Angela M Wood, Adam S Butterworth,[...]. JAMA 2019
279
11

Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
Stefano Romeo, Wu Yin, Julia Kozlitina, Len A Pennacchio, Eric Boerwinkle, Helen H Hobbs, Jonathan C Cohen. J Clin Invest 2009
296
11

Triglycerides and cardiovascular disease.
Børge G Nordestgaard, Anette Varbo. Lancet 2014
712
11

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
11

Angptl3 regulates lipid metabolism in mice.
Ryuta Koishi, Yosuke Ando, Mitsuru Ono, Mitsuru Shimamura, Hiroaki Yasumo, Toshihiko Fujiwara, Hiroyoshi Horikoshi, Hidehiko Furukawa. Nat Genet 2002
288
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.